BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38619274)

  • 21. Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.
    Kiniwa Y; Nakamura K; Mikoshiba A; Ashida A; Akiyama Y; Morimoto A; Okuyama R
    BMC Cancer; 2021 Mar; 21(1):287. PubMed ID: 33731038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
    Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
    Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.
    Glitza IC; Rohlfs M; Guha-Thakurta N; Bassett RL; Bernatchez C; Diab A; Woodman SE; Yee C; Amaria RN; Patel SP; Tawbi H; Wong M; Hwu WJ; Hwu P; Heimberger A; McCutcheon IE; Papadopoulos N; Davies MA
    ESMO Open; 2018; 3(1):e000283. PubMed ID: 29387478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice.
    Felici C; Mannavola F; Stucci LS; Duda L; Cafforio P; Porta C; Tucci M
    BMC Cancer; 2022 Jul; 22(1):754. PubMed ID: 35820816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease.
    Khaled ML; Ren Y; Kundalia R; Alhaddad H; Chen Z; Wallace GC; Evernden B; Ospina OE; Hall M; Liu M; Darville LNF; Izumi V; Chen YA; Pilon-Thomas S; Stewart PA; Koomen JM; Corallo SA; Jain MD; Robinson TJ; Locke FL; Forsyth PA; Smalley I
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photoacoustic and photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluid in vivo and ex vivo.
    Nedosekin DA; Juratli MA; Sarimollaoglu M; Moore CL; Rusch NJ; Smeltzer MS; Zharov VP; Galanzha EI
    J Biophotonics; 2013 Jun; 6(6-7):523-33. PubMed ID: 23681943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
    Ferguson SD; Bindal S; Bassett RL; Haydu LE; McCutcheon IE; Heimberger AB; Li J; O'Brien BJ; Guha-Thakurta N; Tetzlaff MT; Tawbi H; Davies MA; Glitza IC
    J Neurooncol; 2019 May; 142(3):499-509. PubMed ID: 30847840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo culture of circulating tumor cells using magnetic force-based coculture on a fibroblast feeder layer.
    Yamamoto S; Shimizu K; Fei J; Iwata H; Okochi M; Nakanishi H; Honda H
    Biotechnol J; 2016 Nov; 11(11):1433-1442. PubMed ID: 27731546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide
    Puri S; Malani R; Chalmers A; Kerrigan K; Patel SB; Monynahan K; Cannon L; Blouw B; Akerley W
    Neurooncol Adv; 2024; 6(1):vdad150. PubMed ID: 38196737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.
    Lin SY; Chang SC; Lam S; Irene Ramos R; Tran K; Ohe S; Salomon MP; Bhagat AAS; Teck Lim C; Fischer TD; Foshag LJ; Boley CL; O'Day SJ; Hoon DSB
    Clin Chem; 2020 Jan; 66(1):169-177. PubMed ID: 31672856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanoma.
    Galanzha EI; Menyaev YA; Yadem AC; Sarimollaoglu M; Juratli MA; Nedosekin DA; Foster SR; Jamshidi-Parsian A; Siegel ER; Makhoul I; Hutchins LF; Suen JY; Zharov VP
    Sci Transl Med; 2019 Jun; 11(496):. PubMed ID: 31189720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs).
    Tayoun T; Faugeroux V; Oulhen M; Aberlenc A; Pawlikowska P; Farace F
    Cells; 2019 Sep; 8(10):. PubMed ID: 31557946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The RPL/RPS gene signature of melanoma CTCs associates with brain metastasis.
    Bowley TY; Lagutina IV; Francis C; Sivakumar S; Selwyn RG; Taylor E; Guo Y; Fahy BN; Tawfik B; Marchetti D
    Cancer Res Commun; 2022 Nov; 2(11):1436-1448. PubMed ID: 36407834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapy.
    Kumthekar PU; Blouw B; Corkos P; Nagpal S; Tripathy A; Piccioni D; Youssef M
    Front Oncol; 2024; 14():1402651. PubMed ID: 38826788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
    Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V
    J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis.
    Ruan H; Zhou Y; Shen J; Zhai Y; Xu Y; Pi L; Huang R; Chen K; Li X; Ma W; Wu Z; Deng X; Wang X; Zhang C; Guan M
    Clin Transl Med; 2020 Dec; 10(8):e246. PubMed ID: 33377642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Acetyl-L-cysteine Promotes
    Teng T; Kamal M; Iriondo O; Amzaleg Y; Luo C; Thomas A; Lee G; Hsu CJ; Nguyen JD; Kang I; Hicks J; Smith A; Sposto R; Yu M
    Mol Cancer Res; 2021 Mar; 19(3):441-450. PubMed ID: 33303691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
    Varney ML; Olsen KJ; Mosley RL; Singh RK
    J Interferon Cytokine Res; 2005 Nov; 25(11):674-83. PubMed ID: 16318581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis.
    Le Rhun E; Tu Q; De Carvalho Bittencourt M; Farre I; Mortier L; Cai H; Kohler C; Faure GC
    Med Oncol; 2013 Jun; 30(2):538. PubMed ID: 23504338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.